Maryland Transit Administration – Disabled Reduced Fare Program – Opioid Treatment Program Patients
What this bill does
Requiring the Maryland Transit Administration to make available to opioid treatment programs monthly transit passes that are for use by patients of opioid treatment programs who qualify for the administration's Disabled Reduced Fare Program and may be issued to patients on site at opioid treatment programs by staff; requiring the passes to be made available at a reduced price that reflects the price of a monthly pass issued under the Disabled Reduced Fare Program as of October 1, 2020; etc.
Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.
Testimony (5)
MGA witness list| Position | Witness | Organization | Testimony |
|---|---|---|---|
| FAV | Ali, LCAD-C,LCPC, Bilal | CMDS | Position only |
| FAV | Harris, Alfred | Client | Position only |
| FAV | Thompson, Wayne | Client | Position only |
| FAV | Brocato, Barbaralobbyist | Individual | Oral + Written (PDF) |
| FAV | Senator Carter, Senator Carterlegislator | Individual | Oral + Written (PDF) |